Evaluation of additional intraocular pressure reduction with once daily, evening administration of travoprost 0.004%, once daily, evening administration of travoprost 0.004%/timolol 0.5% fixed combination and once daily, evening administration of travoprost 0.004%/timolol 0.5% fixed combination plus twice daily brinzolamide 1% in open angle glaucoma
- Conditions
- Open-angle glaucoma
- Registration Number
- EUCTR2007-000811-27-HU
- Lead Sponsor
- Department of Ophthalmology, SEmmelweis University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Chronic open-angle galucoma in adults (older than 18 y)
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Other eye diseases, contraindications against beta-blockers and sulfonamides, lactation and pregnancy
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: To investigate additional IOP decrease in a tripple combination of IOP lowering medications;Secondary Objective: ;Primary end point(s): IOP lowering at each 4 week period of the treatment
- Secondary Outcome Measures
Name Time Method